Hanmiyeon Holds Regular Seminar... "Discussion on Medical Reform Plans in Republic of Korea"

The Korea Future Medical Innovation Research Association (hereinafter referred to as Hanmiyeon) announced on the 13th that it successfully held its 5th regular seminar at the Kensington Hotel in Yeouido, Seoul.

Hanmiyeon is a research association formed by experts from various fields of the medical field. It positions itself as a think tank that researches and proposes future medical innovation policies to enhance Korea's medical competitiveness and future value.

At the seminar held on the 12th, in-depth discussions were conducted on the "Direction of Medical Reform in the Republic of Korea." Previously, Hanmiyeon proposed policies related to the training of physician-scientists under the theme of "Overall Healthcare 4.0 Medical System" at the first seminar in April last year.

At the second seminar in June of the same year, the topic was "Digital Healthcare Technology Innovation," and a heated discussion related to digital healthcare took place. The third seminar presented issues and improvement directions of regional healthcare under the theme "Direction of Regional Medical Innovation." The fourth seminar gathered experts from various fields to discuss the direction under the theme "Training Physician-Scientists for the Future of Korea's Medical Industry."

Attendees at this seminar included Kang Daehee, president of the Telemedicine Society and co-representative of Hanmiyeon; Lim Jong-yoon, internal director of Hanmi Pharmaceutical; Lee Kang-deok, mayor of Pohang; Jeffrey Glenn, professor at Stanford University, USA; and Cho Nam-jun, professor at Nanyang Technological University, Singapore. Former Democratic Party member of the National Assembly Kim Sang-hoon, Democratic Party member Cho Seung-rae, and People Power Party member Choi Su-jin also graced the event with congratulatory remarks.

Kim Sang-hoon, chairman of the People Power Party Policy Committee, said in his congratulatory speech, "Amid ongoing legislative conflicts such as budget cuts for the country's only 'Severe Trauma Specialist Training Center,' I hope the Korea Future Medical Innovation Research Association will serve as an opportunity for frank communication between the National Assembly and the medical community and to prepare fundamental measures for medical normalization."

Additionally, National Assembly member Choi Su-jin stated, "I will do my best to establish an institutional foundation, including regulatory improvements and expanded support, for the development of the 'bio-medical industry,' an important axis leading future medical innovation," adding, "I hope the various topics discussed at this seminar will serve as an important foundation for setting the practical direction of medical reform in the Republic of Korea."

In the keynote speech, Yoon Seok-jun, dean of the Graduate School of Public Health at Korea University, emphasized a future-oriented medical reform approach that responds to the new era under the theme "Current Status and Reform Direction of Our Country's Health Care System." Dean Yoon pointed out, "The current medical system's problems include the increasing medical utilization due to aging and the severely insufficient control systems," emphasizing that "adherence to the medical delivery system, management of the number of hospital beds, and essential medical care through active government intervention and support can be the answers to solving these problems."

In the first session of the seminar, Lee Kyung-soo, vice president of management strategy at Yeungnam University, gave a presentation on the theme "Direction of Regional Medical Innovation." Based on his experience working in emergency response headquarters during the COVID-19 period, Vice President Lee emphasized the role of regional crisis response.

In the second session, Hwang Man-soon, CEO of Korea Investment Partners, introduced the current status, prospects, and major achievements of domestic and international bio-industry investments under the theme "Development of the Bio-Medical Industry," adding suggestions for the development of Korea's bio-medical industry through global bio investment trends and key factors.

In the subsequent panel discussion, moderated by co-representative Kang Daehee, participants included Dean Yoon Seok-jun, Vice President Lee Kyung-soo, CEO Hwang Man-soon, and Han Sung-joon, CEO of Core Group and chairman of Hanmiyeon's operating committee. The discussion covered strategies for approaching digital healthcare to leap forward as a global leader in AI utilization, the necessity of establishing a national defense bio system, and institutional equipment needed for this purpose.

Han Sung-joon, chairman of Hanmiyeon's operating committee, emphasized, "As the AI industry has recently established itself as a global trend, the government also needs a strategic approach focusing on digital healthcare to leap forward as a global leader." He particularly stated, "Having realized the importance of vaccine sovereignty through the COVID-19 pandemic, it is time to build a swift and efficient 'Korean-style national defense bio' system more than ever."

This content was produced with the assistance of AI translation services.